Search

Displaying results 3301 - 3310 of 6076 in total
  1. Drug

    Acadesine

    go.drugbank.com/drugs/DB04944
    Investigational

    Acadesine has been granted Orphan Drug Designation for B-CLL in the EU. … Acadesine (AICA-riboside) is a purine nucleoside analog with anti-ischemic properties that is currently being studied (Phase 3) for the prevention of adverse cardiovascular outcomes in patients undergoing

  2. Drug

    AZD-7295

    go.drugbank.com/drugs/DB12724
    Investigational

    AZD7295 has been investigated for the treatment of Hepatitis C.

  3. Drug

    Glyceryl Trioleate

    go.drugbank.com/drugs/DB13038
    Investigational

    Glyceryl Trioleate has been investigated for the treatment of Adrenoleukodystrophy.

  4. Drug

    Surinabant

    go.drugbank.com/drugs/DB13070
    Investigational

    Surinabant has been investigated for the treatment of Smoking Cessation.

  5. Drug

    Gisadenafil

    go.drugbank.com/drugs/DB11902
    Investigational

    Gisadenafil has been investigated for the treatment of Prostatic Hyperplasia.

  6. Drug

    Napabucasin

    go.drugbank.com/drugs/DB12155
    Investigational

    Napabucasin has been investigated for the treatment of Colorectal Carcinoma.

  7. Drug

    Puerarin

    go.drugbank.com/drugs/DB12290
    Investigational

    Puerarin has been investigated for the treatment of Alcohol Abuse.

  8. Drug

    Piclozotan

    go.drugbank.com/drugs/DB12361
    Investigational

    Piclozotan has been investigated for the treatment of Parkinson's Disease.

  9. Drug

    Glyceryl Trierucate

    go.drugbank.com/drugs/DB12528
    Investigational

    Glyceryl Trierucate has been investigated for the treatment of Adrenoleukodystrophy.

  10. Drug

    Cerlapirdine

    go.drugbank.com/drugs/DB12229
    Investigational

    Cerlapirdine has been investigated for the treatment of Alzheimer Disease.